Compare Globus Medical Inc. Class A Common Stock (GMED) vs Rush Street Interactive Inc (RSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Rush Street Interactive Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Rush Street Interactive Inc trades at $18.31 (market cap $2.20B). The key difference: Globus Medical Inc. Class A Common Stock is far larger — about 4.7× Rush Street Interactive Inc's market cap, and Globus Medical Inc. Class A Common Stock is trading nearer its 52-week high, Rush Street Interactive Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Rush Street Interactive Inc for 13 Days on average.
| GMED | RSI | |
|---|---|---|
Market Cap | $10.25B | $2.20B |
Volume | 1,108,124 | 4,146,093 |
Sector | Health | Consumer Cyclical |
52-Week High | $96.82 | $34.52 |
52-Week Low | $58.33 | $15.89 |
Typical Hold Time | 0 Days | 13 Days |
Enterprise Value | $9.76B | $1.87B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
RSI trades at $19.07, up 1.92% with bearish technical signals but strong analyst support. The company shows revenue growth to $1.13B in 2025 with improving cash flow, though net margins remain thin at 2.33%. Recent Q2 2026 earnings beat expectations at $0.15 EPS, while institutional interest grows with BlackRock's $448M investment in August 2026.
Outlook remains positive with 77% analyst buy ratings and $33.75 price target offering 77% upside. Key risks include competitive pressures in online gaming and margin compression. The stock presents growth potential but requires monitoring of profitability trends and market sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Rush Street Interactive Inc
Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →
